Showing results (451-460 of 474) with videos related to
Sort By:
Pageof 48
Oncotarget|October 21, 2015
Genetic variant of PRKAA1 and gastric cancer risk in an eastern Chinese populationLi-Xin Qiu, Jing He, Lei Cheng, et al.Oncotarget|February 6, 2016
PSCA polymorphisms and gastric cancer susceptibility in an eastern Chinese populationLi-Xin Qiu, Lei Cheng, Jing He, et al.Oncotarget|February 25, 2016
Genetic variant rs4072037 of MUC1 and gastric cancer risk in an Eastern Chinese populationLi-Xin Qiu, Rui-Xi Hua, Lei Cheng, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 2, 2018
Total neoadjuvant treatment (CAPOX plus radiotherapy) for patients with locally advanced rectal cancer with high risk factors: A phase 2 trialXin Wang, Yongyang Yu, Wenjian Meng, et al.Molecular Oncology|January 18, 2023
Rational combination of SHP2 and mTOR inhibition for the treatment of hepatocellular carcinomaAntonio Mulero-Sánchez, Christel F A Ramirez, Aimée du Chatinier, et al.Journal of Human Genetics|April 22, 2020
Y-chromosome evidence confirmed the Kerei-Abakh origin of Aksay KazakhsShao-Qing Wen, Chang Sun, Dan-Lu Song, et al.Nature|October 4, 2019
Inducing and exploiting vulnerabilities for the treatment of liver cancerCun Wang, Serena Vegna, Haojie Jin, et al.Plos Biology|December 7, 2016
Natural Variation in Arabidopsis Cvi-0 Accession Reveals an Important Role of MPK12 in Guard Cell CO2 SignalingLiina Jakobson, Lauri Vaahtera, Kadri Tõldsepp, et al.Cell Reports|October 10, 2024
SSRI antidepressant citalopram reverses the Warburg effect to inhibit hepatocellular carcinoma by directly targeting GLUT1Fangyuan Dong, Kang He, Shan Zhang, et al.Elife|February 9, 2026
Citalopram exhibits immune-dependent anti-tumor effects by modulating C5aR1+ TAMsFangyuan Dong, Shan Zhang, Kaiyuan Song, et al.Pageof 48